RxSight
Stock Forecast, Prediction & Price Target
RxSight Financial Estimates
RxSight Revenue Estimates
RxSight EBITDA Estimates
RxSight Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $22.59M N/A | $49.00M 116.90% | $89.07M 81.77% | Avg: $180.87M Low: $168.64M High: $193.21M avg. 103.05% | Avg: $221.80M Low: $212.80M High: $231.15M avg. 22.62% | Avg: $254.5M Low: $244.18M High: $265.22M avg. 14.74% | Avg: $288.6M Low: $276.89M High: $300.76M avg. 13.39% |
Net Income
% change YoY
| $-48.68M N/A | $-66.75M -37.10% | $-48.60M 27.18% | Avg: $-18.87M Low: $-25.49M High: $-10.68M avg. 61.17% | Avg: $-9.64M Low: $-21.01M High: $2.06M avg. 48.87% | Avg: $-4.82M Low: $-5.08M High: $-4.56M avg. 50.00% | Avg: $-9.30M Low: $-9.81M High: $-8.81M avg. -92.85% |
EBITDA
% change YoY
| $-52.73M N/A | $-61.80M -17.19% | $-41.03M 33.59% | Avg: $-163.31M Low: $-174.46M High: $-152.27M avg. -297.97% | Avg: $-200.27M Low: $-208.71M High: $-192.14M avg. -22.62% | Avg: $-229.79M Low: $-239.48M High: $-220.47M avg. -14.74% | Avg: $-260.58M Low: $-271.56M High: $-250.01M avg. -13.39% |
EPS
% change YoY
| -$1.78 N/A | -$2.41 -35.39% | -$1.41 41.49% | Avg: -$0.5 Low: -$0.74 High: -$0.31 avg. 64.8% | Avg: -$0.25 Low: -$0.61 High: $0.06 avg. 50.46% | Avg: -$0.14 Low: -$0.15 High: -$0.13 avg. 43.05% | Avg: -$0.27 Low: -$0.28 High: -$0.26 avg. -92.85% |
Operating Expenses
% change YoY
| $57.30M N/A | $84.64M 47.71% | $103.85M 22.68% | Avg: $409.02M Low: $381.37M High: $436.93M avg. 293.85% | Avg: $501.57M Low: $481.23M High: $522.71M avg. 22.62% | Avg: $575.51M Low: $552.17M High: $599.77M avg. 14.74% | Avg: $652.62M Low: $626.16M High: $680.13M avg. 13.39% |
FAQ
What is RxSight stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 16.79% in 2025-2028.
We have gathered data from 5 analysts. Their low estimate is -25.49M, average is -18.87M and high is -10.68M.
What is RxSight stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 38.45% in 2025-2028.
We have gathered data from 6 analysts. Their low revenue estimate is $168.64M, average is $180.87M and high is $193.21M.
What is RxSight stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 16.36% in 2025-2028.
We have gathered data from 5 analysts. Their low earnings per share estimate is -$0.74, average is -$0.5 and high is $-0.31.
What is the best performing analyst?
In the last twelve months analysts have been covering RxSight stock. The most successful analyst is Curry Baker.